Lobby Days Recap – 214 meetings in two days!
This week’s 2016 Lymphedema Lobby Days were a huge success! Over 70 patient advocates, hailing from 21 states plus the District of Columbia, met with 214 offices from 38 different
This week’s 2016 Lymphedema Lobby Days were a huge success! Over 70 patient advocates, hailing from 21 states plus the District of Columbia, met with 214 offices from 38 different
Today and tomorrow, over 70 patient advocates from around the country will be meeting with over 150 congressional offices! Please help increase the impact of our visit by calling your
Thank you to everyone who helped us reach this milestone! You can see the complete list of 201 House cosponsors here, and 13 Senate cosponsors here. If you don’t see
In exactly two weeks from today, patient advocates from around the country will spend two days in Washington, DC, meetings with congressional offices to increase support for the Lymphedema Treatment
Just four days left to register to take part in our 2016 Lymphedema Lobby Days, April 18th-20th in Washington, DC! Monday, April 4th is the registration deadline to join the
Register now for our 2016 Lymphedema Lobby Days, taking place April 18th-20th in Washington, DC! We are just three weeks away from the registration deadline of April 4th, and one
Happy Lymphedema Awareness Day! Today marks the 22nd annual Lymphedema Awareness Day, a tradition started by Saskia Thiadens, founder of the National Lymphedema Network (NLN). Each year, on this day,
We now have 189 Representatives cosponsoring our House bill, HR 1608, and 11 Senators cosponsoring our recently introduced Senate companion bill, S 2373. Click here for the House list, and
March is Lymphedema Awareness Month, and March 6th is Lymphedema Awareness Day! If you are hosting or attending an event, or just want to increase awareness in your area, we
Join our email list to learn about
changes to insurance coverage, advocacy actions,
new educational materials and more.
Subscribers receive approximately
one email per week with information
from both of our organizations.

